Skip to content

A Comparison of the Effects of Intraoperative Norepinephrine and Phenylephrine on Postoperative Gastrointestinal Function Recovery in Patients Undergoing Liver Surgery: A Prospective Cohort Study

A Comparison of the Effects of Intraoperative Norepinephrine and Phenylephrine on Postoperative Gastrointestinal Function Recovery in Patients Undergoing Liver Surgery: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122037
Enrollment
Unknown
Registered
2026-04-08
Start date
2026-04-08
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Gastrointestinal Function Recovery

Interventions

The group treated with norepinephrine/doxepin:None

Sponsors

The First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for liver resection surgery under general anesthesia; 2. Age >= 18 years old; 3. ASA grade I - III; 4. Need to use vasoactive drugs due to hemodynamic fluctuations during the operation; 5. Complete anesthesia records available; 6. Obtained written informed consent from the patients.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Simultaneous use of norepinephrine and desoxynorepinephrine during the operation; 3. Continuous or repeated use of other vasoactive drugs that may significantly affect visceral perfusion or gastrointestinal motility (such as dopamine, epinephrine, etc.) during the operation; 4. Death due to any cause within 24 hours after the operation; 5. Hospital stay after the operation <= 3 days; 6. Severe renal insufficiency or requiring dialysis; 7. Severe liver insufficiency; 8. Preoperative presence of intestinal obstruction, active inflammatory bowel disease, abdominal infection, etc.; 9. Long-term use of opioid drugs; 10. Unwilling or unable to cooperate in completing the experiment.

Design outcomes

Primary

MeasureTime frame
Incidence of the composite endpoint of "tolerance of solid food and having had defecation " within 96 hours postoperatively;

Secondary

MeasureTime frame
Time to first flatus;Time to first defecation;Time to first tolerance of oral intake;Time to first tolerance of solid food;Time to first ambulation;Incidence of postoperative nausea and vomiting;Postoperative pain scores;Postoperative analgesic consumption;Occurrence of perioperative adverse events;First postoperative routine blood test results;

Countries

China

Contacts

Public ContactBo Fang

The First Hospital of China Medical University

bfang@cmu.edu.cn+86 135 9165 2713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026